CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (17,406)	$ (51,984)
Adjustments to reconcile net loss to net cash used in operating activities -
Depreciation and amortization	3,466	1,564
Amortization of deferred financing costs, including original issue discount	310	129
Accretion of Preferred Series B Shares and Second Lien Term Loan	1,126	977
Noncash change in warrant shares	0	31,027
Noncash interest expense	2,865	965
Noncash lease expense	1,386	731
Allowance for credit losses	1,313	79
Provision for deferred income taxes	559	247
Stock compensation expense	68	473
Other noncash items	155	790
Changes in assets and liabilities
Accounts receivable	(2,779)	(4,669)
Prepaid expenses and other current assets	1,452	1,502
Other assets	4,866	(544)
Accounts payable and accrued liabilities	4,894	(7,569)
Deferred revenue	(539)	816
Operating lease liabilities	(820)	137
Income taxes	2,826	(32)
Other liabilities	(4,635)	650
Net cash used in operating activities	(893)	(24,711)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(277)	(93)
Purchases of internally-created software	0	(146)
Cash paid in acquisitions, net of cash acquired	0	(6,847)
Other investing	0	100
Net cash used in investing activities	(277)	(6,986)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from long-term debt	0	38,800
Payments for debt-related costs	0	(1,618)
Proceeds from issuance of class A common stock	8	0
Repurchases of class A common stock	0	(7)
Finance lease principal payments	(233)	0
Settlement of tax withholding obligations	(95)	(163)
Net cash (used in) provided by financing activities	(320)	37,012
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(1,490)	5,315
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
Beginning of period	6,933	7,071
End of period	5,443	12,386
SUPPLEMENTAL DISCLOSURES:
Cash paid for interest	3,090	739
Cash paid for income taxes	0	0
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING:
Capital expenditures received in exchange for liabilities included in deferred revenue	$ 123	$ 0